Timothy Jackson
Endocrinology, Diabetes & Metabolism · Bridgeport, WVNPI 1255444766
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.3% of the total across 397 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 22.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $2,791 and has fallen 99.1% since, to $25 in 2025.
Across 397 payments — averaging $17.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$2K
- AstraZeneca$798
- Lilly USA, LLC$694
- Dexcom, Inc.$661
- Sanofi-aventis U.S. LLC$604
- Abbott$544
- plus $2K from 20 others
What the payments were for
- Food & beverage$6,91497%
- Education$1943%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 91 | $1,560 |
| AstraZeneca(2 entities) | 53 | $798 |
| Lilly USA, LLC | 37 | $694 |
| Dexcom, Inc. | 26 | $661 |
| Sanofi-aventis U.S. LLC | 36 | $604 |
| Abbott | 33 | $544 |
| Amgen | 25 | $533 |
| Boehringer Ingelheim | 17 | $255 |
| Medtronic(2 entities) | 5 | $215 |
| Merck | 11 | $158 |
| Mannkind Corporation | 10 | $157 |
| Xeris Pharmaceuticals, Inc. | 7 | $114 |
| Amarin Pharma, Inc. | 7 | $106 |
| Bayer | 6 | $97 |
| AbbVie | 5 | $87 |
| IBSA Pharma Inc. | 5 | $84 |
| Zealand Pharma US, Inc. | 4 | $72 |
| Nevro Corp. | 3 | $54 |
| Pfizer | 3 | $54 |
| Recordati_rare_diseases_inc. | 3 | $47 |
| Insulet Corporation | 2 | $46 |
| GRT US Holding, Inc. | 2 | $40 |
| Esperion Therapeutics, Inc. | 2 | $39 |
| EUSA Pharma (US) LLC | 2 | $35 |
| Johnson & Johnson | 1 | $35 |
| Ipsen Biopharmaceuticals, Inc | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,107 in reported general payments places this provider in the 75th percentile of 57 endocrinology, diabetes & metabolism providers in West Virginia.
See all endocrinology, diabetes & metabolism providers in West Virginia →
Other endocrinology, diabetes & metabolism in Bridgeport
- Jeremy SouleBridgeport$109K
- John EplingBridgeport$28K
- Daniel MaciasHuntington$686K
- Zachary KistkaMartinsburg$120K
- Philip RyanMartinsburg$35K
- Greta GuyerSouth Charleston$22K
- Arlene FederWeirton$20K
- Ziad KahwashSouth Charleston$17K
- Ayman ElkadryHuntington$13K
- Jessica PeriniMorgantown$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.